IDH1突变神经胶质瘤治疗

搜索文档
Nuvation Bio (NUVB) 2025 Conference Transcript
2025-09-05 03:10
Nuvation Bio (NUVB) 2025 Conference September 04, 2025 02:10 PM ET Speaker0It's my pleasure to introduce Innovation Bio. With us we have CEO, founder and president David Hung, and CFO Philippe Sauvage. My name is Daniel Bronderer. I'm a biotechnology associate here at Cantor. And perhaps just for the audience who is maybe a little bit less familiar with Nuvation Bio's story, can you level set on eptrozy launch and what you're expecting over the next six to twelve months?Speaker1Trozee is our drug for Rossma ...